The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

[1]  G. Hoxhaj,et al.  The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism , 2019, Nature Reviews Cancer.

[2]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[3]  D. Felsher,et al.  The MYC oncogene is a global regulator of the immune response. , 2018, Blood.

[4]  C. Dang,et al.  IRE1&agr; RNase–dependent lipid homeostasis promotes survival in Myc-transformed cancers , 2018, The Journal of clinical investigation.

[5]  Sean M. Hartig,et al.  Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer , 2018, The Journal of clinical investigation.

[6]  L. Penn,et al.  MYC Deregulation in Primary Human Cancers , 2017, Genes.

[7]  R. Zare,et al.  Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma , 2017, Proceedings of the National Academy of Sciences.

[8]  R. Murphy,et al.  Tandem mass spectrometry of novel ether-linked phospholipid analogs of anionic pulmonary surfactant phospholipids. , 2016, Rapid communications in mass spectrometry : RCM.

[9]  Kimberley Louise Kaufman Alexander-Kaufman,et al.  In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue. , 2016, Cancer genomics & proteomics.

[10]  R. Mitra,et al.  Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice , 2016, Aging.

[11]  V. Dolinsky,et al.  Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins. , 2016, Biochimica et biophysica acta.

[12]  S. Ong,et al.  SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP , 2016, Proceedings of the National Academy of Sciences.

[13]  D. Muddiman,et al.  Infrared matrix-assisted laser desorption electrospray ionization mass spectrometry imaging analysis of biospecimens. , 2016, The Analyst.

[14]  Sathesh Bhat,et al.  Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small cell lung cancer in preclinical models , 2016, Nature Medicine.

[15]  S. Dupont,et al.  Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways. , 2016, Trends in cell biology.

[16]  L. Chung,et al.  SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer , 2016, Oncotarget.

[17]  D. Pei,et al.  Srebp‐1 Interacts with c‐Myc to Enhance Somatic Cell Reprogramming , 2016, Stem cells.

[18]  T. Terada,et al.  Enzymatic measurement of phosphatidylglycerol and cardiolipin in cultured cells and mitochondria , 2015, Scientific Reports.

[19]  M. Viant,et al.  Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids. , 2015, Cancer research.

[20]  R. Zare,et al.  MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism , 2015, Proceedings of the National Academy of Sciences.

[21]  M. Henriksson,et al.  Impact of MYC in regulation of tumor cell metabolism. , 2015, Biochimica et biophysica acta.

[22]  A. Kimmelman,et al.  Metabolic Dependencies in RAS-Driven Cancers , 2015, Clinical Cancer Research.

[23]  J. Hurley,et al.  Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. , 2015, Cancer cell.

[24]  Yu Hu,et al.  SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism , 2015, Tumor Biology.

[25]  R. Hammer,et al.  Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance[S] , 2014, Journal of Lipid Research.

[26]  E. Prochownik,et al.  c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. , 2014, The Journal of Biological Chemistry.

[27]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[28]  Marco J. Morelli,et al.  Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis , 2014, Nature.

[29]  R. Tibshirani,et al.  Alteration of the lipid profile in lymphomas induced by MYC overexpression , 2014, Proceedings of the National Academy of Sciences.

[30]  S. McMahon.  MYC and the control of apoptosis. , 2014, Cold Spring Harbor perspectives in medicine.

[31]  D. Felsher,et al.  MYC activation is a hallmark of cancer initiation and maintenance. , 2014, Cold Spring Harbor perspectives in medicine.

[32]  K. Larsson,et al.  Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors , 2014, PloS one.

[33]  D. Zadravec,et al.  Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice[S] , 2014, Journal of Lipid Research.

[34]  A. Rosato,et al.  Metabolic control of YAP and TAZ by the mevalonate pathway , 2014, Nature Cell Biology.

[35]  G. Shui,et al.  CDP-Diacylglycerol Synthetase Coordinates Cell Growth and Fat Storage through Phosphatidylinositol Metabolism and the Insulin Pathway , 2014, PLoS genetics.

[36]  W. Shao,et al.  Sterol Regulatory Element-binding Protein (SREBP) Cleavage Regulates Golgi-to-Endoplasmic Reticulum Recycling of SREBP Cleavage-activating Protein (SCAP)* , 2014, The Journal of Biological Chemistry.

[37]  A. Schulze,et al.  Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development , 2013, Disease Models & Mechanisms.

[38]  F. Jolesz,et al.  Mass spectrometry imaging as a tool for surgical decision-making. , 2013, Journal of mass spectrometry : JMS.

[39]  C. Dang.  MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.

[40]  K. Koda,et al.  Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells. , 2013, International journal of oncology.

[41]  A. Mancuso,et al.  Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. , 2013, Genes & development.

[42]  R. Zare,et al.  Characterization of MYC-induced tumorigenesis by in situ lipid profiling. , 2013, Analytical chemistry.

[43]  L. Montanaro,et al.  Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis. , 2013, Journal of the National Cancer Institute.

[44]  R. Mallampalli,et al.  Surfactant phospholipid metabolism. , 2013, Biochimica et biophysica acta.

[45]  D. Marsh.  Handbook of Lipid Bilayers , 2013 .

[46]  D. Green,et al.  c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.

[47]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[48]  E. Maser,et al.  Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. , 2012, Recent patents on anti-cancer drug discovery.

[49]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[50]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[51]  J. Tamburini,et al.  PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies , 2012, Current Oncology Reports.

[52]  A. Levine,et al.  Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway , 2012, Cell.

[53]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[54]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[55]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[56]  Hongkai Ji,et al.  Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation , 2011, PloS one.

[57]  Liang Cheng,et al.  Nondestructive, Histologically Compatible Tissue Imaging by Desorption Electrospray Ionization Mass Spectrometry , 2011, Chembiochem : a European journal of chemical biology.

[58]  G. Perkins,et al.  Mitochondrial phosphatase PTPMT1 is essential for cardiolipin biosynthesis. , 2011, Cell metabolism.

[59]  Claudio R. Santos,et al.  Regulation of the SREBP transcription factors by mTORC1. , 2011, Biochemical Society transactions.

[60]  Kavya Rakhra,et al.  CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. , 2010, Cancer cell.

[61]  Fionnuala Morrish,et al.  Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry* , 2010, The Journal of Biological Chemistry.

[62]  E. Prochownik,et al.  c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. , 2010, Molecular endocrinology.

[63]  D. Felsher.  MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms. , 2010, Genes & cancer.

[64]  Xiao Han,et al.  A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling. , 2010, Biochimica et biophysica acta.

[65]  R. Wanders,et al.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.

[66]  X. Huang,et al.  Obesity, the PI3K/Akt signal pathway and colon cancer , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[67]  R. Robbins,et al.  LAD-ligation: a murine model of myocardial infarction. , 2009, Journal of visualized experiments : JoVE.

[68]  D. Cao,et al.  Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. , 2009, Biochemical and biophysical research communications.

[69]  K. Reue,et al.  Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. , 2009, American journal of physiology. Endocrinology and metabolism.

[70]  Justin R. Cross,et al.  ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009, Science.

[71]  Jennifer E. Van Eyk,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .

[72]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[73]  R. Houtkooper,et al.  Cardiolipin, the heart of mitochondrial metabolism , 2008, Cellular and Molecular Life Sciences.

[74]  J. Haycock,et al.  c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. , 2007, American journal of physiology. Endocrinology and metabolism.

[75]  R. Cooks,et al.  Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. , 2006, Angewandte Chemie.

[76]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[77]  J. Swinnen,et al.  Increased lipogenesis in cancer cells: new players, novel targets , 2006, Current opinion in clinical nutrition and metabolic care.

[78]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[79]  Yuguang Shi,et al.  Identification and Characterization of a Gene Encoding Human LPGAT1, an Endoplasmic Reticulum-associated Lysophosphatidylglycerol Acyltransferase*[boxs] , 2004, Journal of Biological Chemistry.

[80]  Robert D Cardiff,et al.  Developmental Context Determines Latency of MYC-Induced Tumorigenesis , 2004, PLoS biology.

[81]  Enrique Casado,et al.  PI3K/Akt signalling pathway and cancer. , 2004, Cancer treatment reviews.

[82]  S. Cawley,et al.  Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.

[83]  R. McPherson,et al.  Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[84]  D. Felsher.  Reversibility of oncogene-induced cancer. , 2004, Current opinion in genetics & development.

[85]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[86]  A. Munnich,et al.  Characterization of fatty acid oxidation in human muscle mitochondria and myoblasts. , 2003, Molecular genetics and metabolism.

[87]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[88]  F. Kuhajda,et al.  Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. , 2001, Biochemical and biophysical research communications.

[89]  J. Cleveland,et al.  The Max Network Gone Mad , 2001, Molecular and Cellular Biology.

[90]  B. Kempkes,et al.  Cell cycle activation by c‐myc in a Burkitt lymphoma model cell line , 2000, International journal of cancer.

[91]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[92]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[93]  S. R. Young,et al.  c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. , 1999, Experimental and molecular pathology.

[94]  K. Athenstaedt,et al.  Redundant Systems of Phosphatidic Acid Biosynthesis via Acylation of Glycerol-3-Phosphate or Dihydroxyacetone Phosphate in the Yeast Saccharomyces cerevisiae , 1999, Journal of bacteriology.

[95]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[96]  W. Dowhan,et al.  Regulation of Phosphatidylglycerophosphate Synthase Levels inSaccharomyces cerevisiae * , 1998, The Journal of Biological Chemistry.

[97]  W. Dowhan,et al.  The PEL1 Gene (Renamed PGS1) Encodes the Phosphatidylglycero-phosphate Synthase ofSaccharomyces cerevisiae * , 1998, The Journal of Biological Chemistry.

[98]  C. Sawyers,et al.  Differential complementation of Bcr-Abl point mutants with c-Myc. , 1994, Science.

[99]  C. Sawyers,et al.  Dominant negative MYC blocks transformation by ABL oncogenes , 1992, Cell.

[100]  R. Eisenman,et al.  Myc and Max function as a nucleoprotein complex , 1992, Current Biology.

[101]  M. Griese,et al.  ATP-stimulated inositol phospholipid metabolism and surfactant secretion in rat type II pneumocytes. , 1991, The American journal of physiology.

[102]  J. J. Batenburg,et al.  Regulation and location of phosphatidylglycerol and phosphatidylinositol synthesis in type II cells isolated from fetal rat lung. , 1985, Biochimica et biophysica acta.

[103]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[104]  E. E. Hill,et al.  The selective incorporation of 14C-glycerol into different species of phosphatidic acid, phosphatidylethanolamine, and phosphatidylcholine. , 1968, The Journal of biological chemistry.

[105]  R. Sears,et al.  MYC degradation. , 2014, Cold Spring Harbor perspectives in medicine.

[106]  A. Truax,et al.  ChIP and Re-ChIP assays: investigating interactions between regulatory proteins, histone modifications, and the DNA sequences to which they bind. , 2012, Methods in molecular biology.

[107]  Chris Cheadle,et al.  Array-based nuclear run-on analysis. , 2012, Methods in molecular biology.

[108]  Gregor Eichele,et al.  GenePaint.org: an atlas of gene expression patterns in the mouse embryo , 2004, Nucleic Acids Res..

[109]  J. Quirk,et al.  Effect of myo-inositol on the glycerophospholipid composition of adult and fetal rat lung tissue , 1984, Journal of perinatal medicine.